We investigated the activated partial thromboplastin time prolongation after addition to citrated plasma of a heparin-antithrombin mixture, expressed as the ratio of the APTT carried out in the presence of the heparin mixture divided by the baseline APTT of the same plasma mixture. Thrombophilia defects are recognized in about one third of the patients presenting with a venous thromboembolic event.
A NEW MARKER OF THROMBOPHILIA DETECTED BY USING HEPARIN ANTITHROMBIN COMPLEX
LEPORE, Maria Antonietta;
1999
Abstract
We investigated the activated partial thromboplastin time prolongation after addition to citrated plasma of a heparin-antithrombin mixture, expressed as the ratio of the APTT carried out in the presence of the heparin mixture divided by the baseline APTT of the same plasma mixture. Thrombophilia defects are recognized in about one third of the patients presenting with a venous thromboembolic event.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
